Pamela M.J. McLaughlin
- Molecular Biology
- Oncology top 10%
- Immunology
- Cancer Research
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Martin C. HarmsenMonika TrzpisMarcel H.J. RuitersLou F. M. H. de LeijBart‐Jan KroesenCharles H.C.M. BuysBernardina T.F. van der GunWim H.A. Dokter
- Topics
- Monoclonal and Polyclonal Antibodies Research (4 papers)Glycosylation and Glycoproteins Research (3 papers)Virus-based gene therapy research (3 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
Pamela M.J. McLaughlin
22 papers receiving 874 citations
Peers
Comparison fields: 5 of 103
- Molecular Biology 456
- Oncology 348
- Immunology 212
- Cancer Research 116
- Radiology, Nuclear Medicine and Imaging 97
Countries citing papers authored by Pamela M.J. McLaughlin
This map shows the geographic impact of Pamela M.J. McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela M.J. McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela M.J. McLaughlin more than expected).
Fields of papers citing papers by Pamela M.J. McLaughlin
This network shows the impact of papers produced by Pamela M.J. McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela M.J. McLaughlin. The network helps show where Pamela M.J. McLaughlin may publish in the future.
Co-authorship network of co-authors of Pamela M.J. McLaughlin
This figure shows the co-authorship network connecting the top 25 collaborators of Pamela M.J. McLaughlin. A scholar is included among the top collaborators of Pamela M.J. McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela M.J. McLaughlin. Pamela M.J. McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 40 | |
| 3 | 5 | |
| 4 | 20 | |
| 5 | 463 | |
| 6 | 21 | |
| 7 | 21 | |
| 8 | 14 | |
| 9 | 33 | |
| 10 | 12 | |
| 11 | 41 | |
| 12 | 23 | |
| 13 | 5 | |
| 14 | 18 | |
| 15 | 4 | |
| 16 | 11 | |
| 17 | The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapy. | 53 |
| 18 | 45 | |
| 19 | 9 | |
| 20 | 19 |
About Pamela M.J. McLaughlin
Pamela M.J. McLaughlin is a scholar working on Oncology, Molecular Biology and Genetics, having authored 22 papers that have together received 893 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Oncology (348 citations), Immunology (212 citations) and Cancer Research (116 citations). Pamela M.J. McLaughlin has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Martin C. Harmsen, Monika Trzpis, Marcel H.J. Ruiters, Lou F. M. H. de Leij, Bart‐Jan Kroesen, Charles H.C.M. Buys, Bernardina T.F. van der Gun, Wim H.A. Dokter, Wijnand Helfrich and Johannes W. A. Smit. Their work appears in journals such as The Journal of Immunology, Journal of Controlled Release and American Journal Of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.